Sign in
CompletedPhase 2

Intranasal Insulin for Posttraumatic Stress Disorder

Key facts

Who runs it
VA Connecticut Healthcare System
Where
West Haven, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 2
People taking part
10 people enrolled
Started
31 Oct 2024
Ended
28 May 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Intranasal insulin
  • Placebo
Record updated
13 July 2026

Who can take part

Age
21 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Male or female, 21-65 years old
  • Current PTSD
  • Able to provide written informed consent

Who cannot take part

  • Changes in doses of psychotropic medications in the past 4 weeks
  • Initiation of individual therapy or counseling in the past 4 weeks
  • Unstable medical condition, clinically determined by a physician
  • Diabetes requiring insulin or oral hypoglycemic agents
  • Current psychotic disorder, bipolar disorder, cognitive disorder in the past 12 months
  • Current substance use disorders (except alcohol, tobacco, or cannabis) in the past 3 months
  • History of claustrophobia
  • Presence of cardiac pacemaker or other electronic device or ferromagnetic metal foreign bodies in vulnerable positions as assessed by a standard pre-MRI safety screening questionnaire
  • Moderate-severe traumatic brain injury
  • Imminent suicidal or homicidal risk
  • Contraindication to Insulin

Where in United States

  • VA Connecticut Healthcare SystemWest Haven, United States

About the trial

What the trial wants to find out

To evaluate if intranasal insulin is effective in reducing PTSD symptoms.

The 2 groups in the trial

  • Intranasal insulinTreatment being tested

    Subjects in this arm will receive 40 IU of intranasal insulin twice a day (80 IU per day).

  • PlaceboTreatment being tested

    Subjects in this arm will receive placebo.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Intranasal Insulin for Treating Posttraumatic Stress Disorder
Record updated
13 July 2026